Intravitreal anti-VEGF therapy in macular oedema secondary to racemose haemangiomatosis of the retina

Autor:	Magdalena Tylus, Joanna Dolar-Szczasny, Jerzy Mackiewicz, Anna Święch-Zubilewicz
Rok vydání:	2017
Předmět:	Anti vegf Pathology medicine.medical_specialty Retina business.industry Retinal Macular oedema CONGENITAL ARTERIOVENOUS MALFORMATION Asymptomatic Surgery chemistry.chemical_compound medicine.anatomical_structure chemistry medicine Racemose haemangioma Subretinal fluid medicine.symptom business
Zdroj:	Ophthalmology Journal. 2:58-60
ISSN:	2450-9930 2450-7873
DOI:	10.5603/oj.2017.0014
Popis:	Racemose haemangiomatosis of the retina is a sporadic, mostly unilateral, congenital arteriovenous malformation (AVM), comprising abnormal junctions between arteries and veins that omit capillaries. Typically, vascular malformations are asymptomatic and incidentally discovered. Advanced changes may be related to the presence of subretinal fluid and exudates, even though these lesions are classified as benign. Many complications can lead to severe or permanent visual impairment. Direct methods of treatment of primary retinal vascular anomalies have not been developed yet. The aim of this case report is to present the anti-VEGF therapy in the treatment macular oedema secondary to racemose haemangioma.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::373ca2c03366359bdf4a2b1b300fba3e https://doi.org/10.5603/oj.2017.0014 Zobrazit plný text záznamu